Search Results for: hepatitis C virus

February 2, 2016May 20, 2016

AbbVie’s Six Hepatitis C Clinical Trials Now Enrolling Patients

News

AbbVie has announced it will initiate six global Phase 3 clinical studies to evaluate the safety and efficacy of two drug candidates: ABT-530, an NS5A inhibitor, and ABT-493, an NS3/4A protease inhibitor, ... Read more

January 28, 2016January 28, 2016

Biomarkers Identified in Age-Related Response to Hepatitis B Vaccine

News

Case Western Reserve University School of Medicine and Merck Research Laboratories researchers have identified biomarkers of immune response and inflammation that can help predict how a patient will respond to ... Read more

January 14, 2016January 14, 2016

Hepatitis E in Pregnant Women Linked to Vitamin Deficiencies, Anemia

News

Researchers are reporting a link between vitamin D and zinc deficiencies and immune dysfunction and hepatitis E infection risk in pregnant women. The research, by scientists at the Johns Hopkins Bloomberg School of Public ... Read more

December 17, 2015December 17, 2015

Benitec’s Hepatitis B Therapy Shows Efficacy in Early Preclinical Study

News

Benitec Biopharma, Ltd., announced that initial in vitro results demonstrated the efficacy of BB-HB-331, a ddRNAi-based therapeutic developed to treat and potentially cure hepatitis B with a single injection. These results were ... Read more

December 15, 2015December 15, 2015

New Chronic Hepatitis B Treatment Available in Cuba

Hepatitis B, News

ABIVAX and the Center for Genetic Engineering and Biotechnology (CIGB) announced that Cuban regulatory authorities have granted their first marketing authorization application for ABX203 (HeberNasvac), a first-in-class vaccine to treat chronic ... Read more

December 8, 2015December 8, 2015

Hepatitis C Patients on Medicaid Often Denied Coverage for New Effective Drugs

News

According to a new study, 46% of Medicaid patients with the chronic hepatitis C virus (HCV) who were prescribed new and highly effective antiviral drugs were denied insurance coverage because the treatments were not considered ... Read more

December 2, 2015December 2, 2015

Medicines Patent Pool Partners With Bristol-Myers Squibb To Bring Hepatitis C Drug To Less Developed Countries

News

The Medicines Patent Pool (MPP) has announced its first license agreement for a hepatitis C medicine, signed with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that has been proved ... Read more

November 24, 2015November 24, 2015

Hepatitis C Drugs Are Costly But Delayed Treatment Is Costlier, Study Says

News

Findings from a recent analysis conducted at the University of California San Francisco show the worth of providing patients with costly drugs that can treat their hepatitis C much earlier than ... Read more

November 19, 2015November 19, 2015

AbbVie’s Chronic Hepatitis C Treatments Working Well in Trials

News

AbbVie recently announced encouraging results from the SURVEYOR clinical trials of its investigational HCV drug regimen, ABT-493 and ABT-530, in non-cirrhotic patients who are positive for chronic hepatitis C virus (HCV) infection. Specifically, ABT-493, an inhibitor of the NS3/4A protease, ... Read more

November 5, 2015November 5, 2015

Two Hepatitis C Drugs Can Cause Liver Injury, FDA Warns

News

Federal health officials are cautioning patients and clinicians about the potential for life-threatening liver injury in two AbbVie drugs used for the treatment of advanced forms of hepatitis C. The Food and Drug ... Read more